Find clinical trials for COVID-19 in Houston, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Houston, TX, USA:
The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...
Phase 3
Houston, Texas, United States and 19 other locations
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Houston, Texas, United States and 152 other locations
Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID...
Phase 2
Houston, Texas, United States and 12 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Houston, Texas, United States and 144 other locations
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...
Phase 4
Sugar Land, Texas, United States and 98 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Houston, Texas, United States and 28 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Houston, Texas, United States and 224 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Houston, Texas, United States and 257 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 3
Houston, Texas, United States and 75 other locations
the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...
Phase 4
Houston, Texas, United States and 150 other locations
Clinical trials
Research sites
Resources
Legal